super responder tirzepatide Super-Responders” to Liraglutide Monotherapy and the Growing Evidence of Efficacy of GLP-1 Analogues in Obesity Management: A Longitudinal Prospective Cohort Study Fascinating research on why some

Eli Lilly announced earlier this year that it would expand the supply and cut the costs of its weight-loss drug Zepbound, again, effectively broadening access to more patients without insurance with its own self-pay pharmacy

Ensure the patient feels confident about incorporating the treatment into daily life

Heres a look at what the clinical studies show about weight loss at different doses

Visit nuvancehealth.org for more information.

Should I see a specialist

These compounds are not approved by the U.S Food and Drug Administration (FDA) for weight loss, but healthcare providers prescribe these compounds off-label for weight loss and improving metabolic health